Chirag Shah

ORCID: 0000-0001-7275-4475 · 2 papers in corpus

rct 2023

Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis

International journal of rheumatic diseases ·doi:10.1111/1756-185x.14462

AIM: YLB113 biosimilar was evaluated in an open-label extension single-arm study to assess long-term safety, efficacy, and immunogenicity in patients with rheumatoid arthritis (RA). We also report post-hoc results on the incidence of inject…

case-report 2006

Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis

Gynecologic Oncology ·doi:10.1016/j.ygyno.2006.06.044

BACKGROUND: Malignant transformation of endometriosis is an infrequent complication of endometriosis. Extragonadal disease is uncommon. CASE: 55-year-old female presented with postmenopausal bleeding. Physical examination revealed a 2-cm p…